Organigram Holdings (TSX.V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., on Friday announced that it has applied to list its common shares on the NASDAQ Global Select Market. The company intends to file a Form 40-F Registration Statement with the United States Securities and Exchange Commission (“SEC”) ahead of its anticipated NASDAQ listing. Additionally, Organigram refiled its annual financial statements for the fiscal years ended 2017 and 2018 to include statements in the audit report of the public accounting firm to assure accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board. The uplisting of the company’s common shares remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements. “As a management team we are seeing increased interest from investors in the U.S. and internationally and believe that having a listing on the NASDAQ will facilitate trading,” Organigram CFO Paolo De Luca stated in the news release. “In addition, based on precedents in the cannabis space, we expect trading volumes to increase which should result in increased liquidity for all investors.”
To view the full press release, visit http://cnw.fm/1lJhc
About Organigram Holdings Inc.
Organigram Holdings Inc.’s wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.
NOTE TO INVESTORS: The latest news and updates relating to OGRMF are available in the company’s newsroom at http://cnw.fm/OGRMF
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CBDW? Ask our Editor
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com